Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling
ABSTRACT New medicines containing classic hallucinogenic and entactogenic psychedelic substance are under development for various psychiatric and neurological disorders. Many of these, including psilocybin,